A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: a double-blind, randomized, 8-week trial.
about
Atypical antipsychotics for psychosis in adolescentsRisperidone versus other atypical antipsychotics for schizophreniaOlanzapine versus other atypical antipsychotics for schizophreniaLamotrigine for schizophreniaAntipsychotic medication for childhood-onset schizophreniaOlanzapine for schizophreniaRisperidone versus olanzapine for schizophreniaManagement of antipsychotic-related weight gainPharmacotherapy of aggression in children and adolescents: efficacy and effect sizeAtypical antipsychotics in the treatment of early-onset schizophreniaAntipsychotic and psychostimulant drug combination therapy in attention deficit/hyperactivity and disruptive behavior disorders: a systematic review of efficacy and tolerabilityEfficacy and safety of pharmacological and psychological interventions for the treatment of psychosis and schizophrenia in children, adolescents and young adults: a systematic review and meta-analysisOnset of action of atypical and typical antipsychotics in the treatment of acute psychosisClozapine versus "high-dose" olanzapine in refractory early-onset schizophrenia: an open-label extension studyNational trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipolar I disorder in adolescent patientsAdverse effects of psychotropic medications in children: predictive factorsQuetiapine versus aripiprazole in children and adolescents with psychosis--protocol for the randomised, blinded clinical Tolerability and Efficacy of Antipsychotics (TEA) trialCognitive efficacy of quetiapine and olanzapine in early-onset first-episode psychosisCardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents.The short-term effects of risperidone-induced hyperprolactinemia on lipid metabolism in drug-naïve children and adolescents.Evidence-based recommendations for monitoring safety of second generation antipsychotics in children and youthPsychopharmacology of conduct disorder: current progress and future directions.Evaluating and treating the prodromal stage of schizophreniaEvaluating movement disorders in pediatric patients receiving risperidone: a comparison of spontaneous reports and research criteria for TDDrug-induced movement disorders in children and adolescents.Metabolic side effects of atypical antipsychotics in children: a literature review.Review of the safety of second-generation antipsychotics: are they really "atypically" safe for youth and adults?Weight change with atypical antipsychotics in the treatment of schizophrenia.The metabolic effects of antipsychotic medications.Review of antipsychotics in children and adolescents.Review of risperidone for the treatment of pediatric and adolescent bipolar disorder and schizophreniaGenomics and the future of pharmacotherapy in psychiatry.Efficacy and tolerability of second-generation antipsychotics in children and adolescents with schizophrenia.The use of antipsychotics in children and adolescents with bipolar disorders.Activating and Tranquilizing Effects of First-Time Treatment with Aripiprazole, Olanzapine, Quetiapine, and Risperidone in Youth.Pharmacological treatment of pathologic aggression in children.Treatment of neurolept-induced tardive dyskinesiaAnticholinergic use in children and adolescents after initiation of antipsychotic therapyWeight gain and metabolic abnormalities during extended risperidone treatment in children and adolescents.
P2860
Q24197475-C8981410-E315-4FB0-8FF4-D3CC18940B2BQ24234950-017D4EB1-01A7-4E34-B038-7B4D6B85A5CBQ24236545-A1CFC69B-87DC-4489-8D1B-A829F3E49105Q24243946-8390E260-C359-40C1-B0A9-C7C8B590A4BEQ24243972-D53CDEBE-E010-41E3-BCDE-93CDCE927CB3Q24244031-B88FAF47-BE7F-43AF-88BE-C5A120A7F437Q24246232-AF1D88B1-F1FF-48A3-991C-0098CC5C94F5Q24610124-119CA4A1-B57D-4C27-BB14-F683237818CDQ24648097-75B6BA75-8B8F-4F07-8E1C-B12871831632Q28083361-779791CC-676C-4AA6-95AD-A194107B596AQ28287983-2B6B008B-AC40-41D0-94B5-6C52E7F48BB6Q28650054-140F3ACB-1A40-424F-AC9F-A53F548F0F99Q33828080-BF6F9B68-D751-4AFB-9411-E7F781391285Q34112064-08B69684-15C4-443B-8AF7-BEF8ED476822Q34187891-3B89C3D8-E0BA-4F03-868A-FEBCED7D058EQ34329829-EB5443DB-F191-45A7-BBFF-BBE9A199F3F8Q34341232-911D091F-B69A-4F36-9FE1-05DFD80D975CQ34486230-C3695699-8B10-45ED-944F-8AE4CCFEF4FBQ34604342-75B1A3B6-269F-4ED0-9F0E-21BE00E5B478Q34613195-9F427D9D-3BD7-4EF4-82DB-4887BFAC84F6Q35028356-D5D13ED2-69FF-4639-901E-31D880E32CCAQ35128405-8B252633-AAA1-4AF3-A825-FA20C0B39C39Q35779213-16FB0D6D-8D82-4FFB-BBB6-9516B8D176F2Q35839631-35AFCCB6-D584-4724-9825-D02EC87CC230Q35924877-3391837B-6C65-48E8-85C7-06768CF0A91DQ36040766-3171F02D-F713-4A22-9A4B-C7649545E59FQ36258561-F03299D7-C4EB-4CC5-AEE6-69E6BB6C74A5Q36302856-67DC2F0F-0626-46FC-ABA2-C171A30551C0Q36310286-AB15C90D-D79B-48A1-AD1E-697F2A0CBA8CQ36577856-681195B3-09FF-4875-9491-EAC0192BFA03Q36613868-3A9A2A85-6CF1-4BCA-BE24-8987FB7CD3CCQ36836750-4F6815DA-33A9-4A78-902B-E5A0C1624F27Q36951758-B050D529-E0E0-41C7-A49B-96C6BD280897Q36965451-468621B7-EE30-40EA-8665-1367F1701F4BQ36979293-96E6FD4C-1429-4836-A49B-E42C43B2B927Q37061277-9A4E196F-B156-4E52-A4D7-480E1F7C1424Q37127437-9DF4AE71-F11C-42AF-AE94-40266F51919AQ37198420-6585A978-B34D-4A49-9422-9CEDAFB6EF80Q37212444-D2D31CF6-7C7E-41FA-9D64-A60C729BD8EAQ37273061-E3800245-3E4F-4D32-A46E-F93F0119508A
P2860
A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: a double-blind, randomized, 8-week trial.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
A pilot study of risperidone, ...... ind, randomized, 8-week trial.
@en
A pilot study of risperidone, ...... ind, randomized, 8-week trial.
@nl
type
label
A pilot study of risperidone, ...... ind, randomized, 8-week trial.
@en
A pilot study of risperidone, ...... ind, randomized, 8-week trial.
@nl
prefLabel
A pilot study of risperidone, ...... ind, randomized, 8-week trial.
@en
A pilot study of risperidone, ...... ind, randomized, 8-week trial.
@nl
P2093
P2860
P356
P1476
A pilot study of risperidone, ...... ind, randomized, 8-week trial.
@en
P2093
Brian B Sheitman
Jeffrey A Lieberman
Linmarie Sikich
Robert A Bashford
Robert M Hamer
P2860
P2888
P304
P356
10.1038/SJ.NPP.1300327
P407
P577
2004-01-01T00:00:00Z